地塞米松在牙髓病学中的研究进展

doi:10.13701/j.cnki.kqyxyj.2023.03.002

摘要/Abstract

摘要： 牙髓疾病是口腔中常见的疾病,机械、化学、微生物和热因素等会刺激牙髓触发炎症免疫反应,引起牙髓血管扩张、免疫细胞聚集,最终导致组织损伤。地塞米松作为糖皮质激素,因具有抗炎、成骨及镇痛作用,在牙髓病学中的应用越来越广泛,在根管治疗、活髓保存术等领域具有较好的应用前景。本文总结了地塞米松在牙髓疾病中的作用机制及应用。

关键词: 地塞米松, 根管治疗, 盖髓, 活髓保存, 口腔医学

Abstract: Dental pulp disease is a common disease in oral cavity. Mechanical, chemical, microbial, and thermal factors will stimulate dental pulp, trigger inflammatory immune response, cause dental pulp vascular dilatation and immune cell aggregation, and finally lead to tissue damage. As a glucocorticoid, dexamethasone is more and more widely used in endodontics because of its anti-inflammatory, osteogenic, and analgesic effects. It has a better practical perspective in the fields of root canal therapy, vital pulp preservation, and so on. This paper summarizes the mechanism and application of dexamethasone in dental pulp diseases.

Key words: dexamethasone, root canal therapy, pulp capping, preservation of living pulp, stomatology

刘晓莉, 李毅. 地塞米松在牙髓病学中的研究进展[J]. 口腔医学研究, 2023, 39(3): 193-196.

LIU Xiaoli, LI Yi. Application of Dexamethasone in Dental Pulp Diseases[J]. Journal of Oral Science Research, 2023, 39(3): 193-196.

参考文献

[1] Khorasani MMY, Hassanshahi G, Brodzikowska A, et al. Role(s) of cytokines in pulpitis: Latest evidence and therapeutic approaches [J]. Cytokine, 2020, 126: 154896.
[2] Quatrini L, Ugolini S. New insights into the cell- and tissue-specificity of glucocorticoid actions [J]. Cell Mol Immunol, 2021, 18(2): 269-278.
[3] Cain DW, Cidlowski JA. After 62 years of regulating immunity, dexamethasone meets COVID-19 [J]. Nat Rev Immunol, 2020, 20(10): 587-588.
[4] Sheikh MH, Solito E. Annexin A1: Uncovering the many talents of an old protein [J]. Int J Mol Sci, 2018, 19(4): 1045.
[5] Bereshchenko O, Migliorati G, Bruscoli S, et al. Glucocorticoid-induced leucine zpper: A novel anti-inflammatory molecule [J]. Front Pharmacol, 2019, 10: 308.
[6] Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age [J]. Nat Rev Immunol, 2018, 18(5): 309-324.
[7] Han L, Wang B, Wang R, et al. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor [J]. Stem Cell Res Ther, 2019, 10(1): 377.
[8] Xie Y, Shen G. Combined effects of fibroblast growth factor 2 and dexamethasone on differentiation of human cementoblasts [J]. Int J Clin Exp Pathol, 2018, 11(3): 1415-1422.
[9] Zhang S, Liu Y, Liang Q. Low-dose dexamethasone affects osteoblast viability by inducing autophagy via intracellular ROS [J]. Mol Med Rep, 2018, 17(3): 4307-4316.
[10] Ma L, Feng X, Wang K, et al. Dexamethasone promotes mesenchymal stem cell apoptosis and inhibits osteogenesis by disrupting mitochondrial dynamics [J]. FEBS Open Bio, 2020, 10(2): 211-220.
[11] Liu W, Zhao Z, Na Y, et al. Dexamethasone-induced production of reactive oxygen species promotes apoptosis via endoplasmic reticulum stress and autophagy in MC3T3-E1 cells [J]. Int J Mol Med, 2018, 41(4): 2028-2036.
[12] Sun F, Zhou JL, Wei SX, et al. Glucocorticoids induce osteonecrosis of the femoral head in rats via PI3K/AKT/FOXO1 signaling pathway [J]. PeerJ, 2022, 10: e13319.
[13] Zieglgänsberger W. Substance P and pain chronicity [J]. Cell Tissue Res, 2019, 375(1): 227-241.
[14] Abdulkhaleq LA, Assi MA, Abdullah R, et al. The crucial roles of inflammatory mediators in inflammation: A review [J]. Vet World, 2018, 11(5): 627-635.
[15] Gul G, Bilgic T, Aydin MA. Evaluation of the effects of preoperative dexamethasone administration on postoperative patient comfort in laparoscopic cholecystectomy [J]. Cureus, 2020, 12(5): e7968.
[16] Southerland WA, Gillis J, Urits I, et al. Intraoperative administration of dexmedetomidine and dexamethasone in local anesthetic infiltration to improve postoperative pain control after posterior cervical fusion [J]. Cureus, 2021, 13(4): e14699.
[17] Bassam S, El-Ahmar R, Salloum S, et al. Endodontic postoperative flare-up: An update [J]. Saudi Dent J, 2021, 33(7): 386-394.
[18] Aksoy F, Ege B. The effect of pretreatment submucosal injections of tramadol and dexamethasone on post-endodontic pain in mandibular molar teeth with symptomatic irreversible pulpitis: a randomized controlled clinical trial [J]. Int Endod J, 2020, 53(2): 176-185.
[19] Yavari HR, Jafari F, Jamloo H, et al. The effect of submucosal injection of corticosteroids on pain perception and quality of life after root canal treatment of teeth with irreversible pulpitis: A randomized clinical trial [J]. J Endod, 2019, 45(5): 477-482.
[20] Konagala RK, Mandava J, Pabbati RK, et al. Effect of pretreatment medication on postendodontic pain: A double-blind, placebo-controlled study [J]. J Conserv Dent, 2019, 22(1): 54-58.
[21] Suresh N, Nagendrababu V, Koteeswaran V, et al. Effect of preoperative oral administration of steroids in comparison to an anti-inflammatory drug on postoperative pain following single-visit root canal treatment-a double-blind, randomized clinical trial [J]. Int Endod J, 2021, 54(2): 198-209.
[22] Evangelin J, Sherwood IA, Abbott PV, et al. Influence of different irrigants on substance P and IL-8 expression for single visit root canal treatment in acute irreversible pulpitis [J]. Aust Endod J, 2020, 46(1): 17-25.
[23] Nagendrababu V, Pulikkotil SJ, Suresh A, et al. Efficacy of local anaesthetic solutions on the success of inferior alveolar nerve block in patients with irreversible pulpitis: a systematic review and network meta-analysis of randomized clinical trials [J]. Int Endod J, 2019, 52(6): 779-789.
[24] Aggarwal V, Singla M, Saatchi M, et al. Preoperative intraligamentary injection of dexamethasone can improve the anesthetic success rate of 2% lidocaine during the endodontic management of mandibular molars with symptomatic irreversible pulpitis [J]. J Endod, 2021, 47(2): 161-168.
[25] Bidar M, Mortazavi S, Forghani M, et al. Comparison of effect of oral premedication with ibuprofen or dexamethasone on anesthetic efficacy of inferior alveolar nerve block in patients with irreversible pulpitis: A prospective, randomized, controlled, double-blind dtudy [J]. Bull Tokyo Dent Coll, 2017, 58(4): 231-236.
[26] Pulikkotil SJ, Nagendrababu V, Veettil SK, et al. Effect of oral premedication on the anaesthetic efficacy of inferior alveolar nerve block in patients with irreversible pulpitis-A systematic review and network meta-analysis of randomized controlled trials [J]. Int Endod J, 2018, 51(9): 989-1004.
[27] Andrei M, Vacaru RP, Coricovac A, et al. The effect of calcium-silicate cements on reparative dentinogenesis following direct pulp capping on animal models [J]. Molecules, 2021, 26(9):2725.
[28] El Ashry SH, Abu-Seida AM, Emara RAJVA. The influence of addition of osteogenic supplements to mineral trioxide aggregate on the gene expression level of odontoblastic markers following pulp capping in dogs [J]. Vet Arh, 2016, 86: 685-697.
[29] Mousavi SA, Ghoddusi J, Mohtasham N, et al. Human pulp response to direct pulp capping and miniature pulpotomy with MTA after application of topical dexamethasone: A randomized clinical trial [J]. Iran Endod J, 2016, 11(2): 85-90.
[30] Zhang M, Ni S, Zhang X, et al. Dexamethasone-loaded hollow hydroxyapatite microsphere promotes odontogenic differentiation of human dental pulp cells in vitro [J]. Odontology, 2020, 108(2): 222-230.
[31] Alagha A, Nourallah A, Alhariri S. Dexamethasone-loaded polymeric porous sponge as a direct pulp capping agent [J]. J Biomater Sci Polym Ed, 2020, 31(13): 1689-1705.
[32] Lim HC, Nam OH, Kim MJ, et al. Delivery of dexamethasone from bioactive nanofiber matrices stimulates odontogenesis of human dental pulp cells through integrin/BMP/mTOR signaling pathways [J]. Int J Nanomedicine, 2016, 11: 2557-2567.